High dose nicotinamide in the treatment of necrobiosis lipoidica.
An open study of high dose nicotinamide in the treatment of 15 patients with necrobiosis lipoidica is reported. Of 13 patients who remained on treatment for more than 1 month, eight improved. Improvement took the form of a decrease in pain and soreness, a decrease in erythema and the healing of ulcers if present, although the skin did not return completely to normal in any patient. There were no significant side-effects, particularly with respect to diabetic control, an important finding as lesions tended to relapse if treatment was stopped.
Handfield-Jones
S
S
Department of Dermatology, Bristol Royal Infirmary, U.K.
Jones
S
S
Peachey
R
R
D000328:Adult; D000368:Aged; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009335:Necrobiosis Lipoidica / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D009536:Niacinamide / Q000008:administration & dosage* / Q000627:therapeutic use
D009536:Niacinamide